European Journal of Medicinal Chemistry p. 45 - 62 (2017)
Update date:2022-08-03
Topics:
Xu, Xiao-li
Yang, Ying-rui
Mo, Xiao-fei
Wei, Jin-lian
Zhang, Xiao-jin
You, Qi-dong
Pancreatic ductal adenocarcinoma (PDAC) is one of the most common type of pancreatic cancer, and has still been the medicinal mystery. New drugs and treatment strategies are urgently needed. In this study, 32 benzofuran derivatives are designed, synthesized and evaluated as potential agents against the pancreatic cancer. Among them, compound 9o with the best physicochemical and pharmacokinetic properties exhibited excellent cytotoxicity against many tumor cell lines. In vivo study showed that compound 9o dramatically suppressed the tumor growth of nude mice. Furthermore, compound 9o could affect the hypoxia environment through Hif-1α/VEGF pathway, resulting in the anti-angiogenic activity. These studies indicated that compound 9o was a promising candidate for the treatment of PDAC, deserving further studies.
View MoreRefine Chemicals Science & Technology Technology Developing Co., Ltd.
Contact:+86-22-87899130
Address:No.12,west keyan road,Tianjin City
website:http://www.easchem.com
Contact:+86-731-89722861 89722891
Address:2/F-4/Bld Colorful Palace, No.605 Changsha Ave, Yuhua Area Changsha Hunan China.
Tianjin Emulsion Science&Technology Development Co.,Ltd
Contact:13901380442
Address:Vake Garden New Town New Yi Bai Road Beichen District Tianjin,China
Contact:+86-10-62651721
Address:29 Yongxing Road, Daxing District,Beijing China
Chengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
Doi:10.1021/jo00196a035
(1984)Doi:10.1002/hlca.19590420624
(1959)Doi:10.1021/ja01520a076
()Doi:10.1021/jm800310g
(2008)Doi:10.1016/j.ejmech.2020.113088
(2021)Doi:10.1016/S0040-4039(01)90005-X
(1984)